Search Results - "Kiljanski, Jacek I"

727-P: Glycemic Effect of Tirzepatide by Duration of Diabetes by DE BLOCK, CHRISTOPHE, MATHIEU, CHANTAL, SAPIN, HELENE, KILJANSKI, JACEK I., PELESHOK, JENNIFER

“…Results of SURPASS-1 through -5 trials have shown robust efficacy of novel dual GIP/GLP-1 receptor agonist tirzepatide (TZP) in people with type 2 diabetes. To…”
Get full text

777-P: Early Weight Loss and Late Metabolic Outcomes in Tirzepatide-Treated Participants with Type 2 Diabetes by LINGVAY, ILDIKO, GIORGINO, FRANCESCO, VAN GAAL, LUC, LIU, MINZHI, RODRÍGUEZ, ÁNGEL, TORCELLO-GOMEZ, AMELIA, KILJANSKI, JACEK I.

“…Tirzepatide (TZP), a novel, once-weekly GIP/GLP-1 receptor agonist, significantly improved glycemic control with robust weight loss vs comparators in the…”
Get full text

729-P: Relationship between Body Weight Change and Glycemic Control with Tirzepatide Treatment in People with Type 2 Diabetes by PEDERSEN, SUE, UMPIERREZ, GUILLERMO E., GIORGINO, FRANCESCO, RODRÍGUEZ, ÁNGEL, THIEU, VIVIAN, SAPIN, HELENE, LANDO, LAURA FERNANDEZ, KARANIKAS, CHRISANTHI A., KILJANSKI, JACEK I.

“…Tirzepatide (TZP) , a novel, once weekly, dual GIP/GLP-1 receptor agonist, is being developed as a glucose lowering agent in type 2 diabetes (T2D) . In the…”
Get full text

743-P: Clinical Factors Associated with Insulin Regression When Adding Tirzepatide in Basal Insulin–Treated Type 2 Diabetes by Wysham, Carol H, Rosenstock, Julio, Tofe, Santiago, Thieu, Vivian, Kiljanski, Jacek I, Lee, Clare, Wang, Hui, Patel, Hiren

“…Introduction & Objective: In the SURPASS-6 trial, tirzepatide (TZP) added to basal insulin glargine U100 significantly improved HbA1c and body weight in…”
Get full text

757-P: Near-Normoglycemia and Insulin Regression Induced by Tirzepatide in Basal Insulin–Treated Type 2 Diabetes by Rosenstock, Julio, Tofe, Santiago, Wysham, Carol H, Thieu, Vivian, Kiljanski, Jacek I, Lee, Clare, Wang, Hui, Patel, Hiren

“…Introduction & Objective: In the SURPASS-6 trial, addition of tirzepatide (TZP) to basal insulin glargine U100 in participants with inadequately controlled…”
Get full text

The ocular muscle cell is a target of the immune system in endocrine ophthalmopathy by Kiljanski, J I, Nebes, V, Wall, J R

“…The exact pathogenic mechanism of thyroid-associated ophthalmopathy (TAO) remains unclear, and extensive studies on this disorder have resulted in often…”
Get more information